← Back to Search

Behavioral Intervention

Light Therapy for Sleep Disorders and Cognitive Impairment

Phase 4
Waitlist Available
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Drug Has Already Been Approved
No Placebo-Only Group
Pivotal Trial

Summary

This trial will test if bright light can help older people sleep better & improve cognitive abilities.

Who is the study for?
This trial is for individuals over the age of 65 who are experiencing mild cognitive impairment. It's not suitable for those with unstable psychiatric or medical conditions, severe depression, or an acute infection.
What is being tested?
The study is testing whether scheduled bright light therapy in the morning and afternoon can help improve sleep quality and reduce sleep fragmentation in older adults with mild cognitive impairment.
What are the potential side effects?
Light therapy is generally safe but may cause eyestrain, headache, nausea, irritability or agitation. People with certain eye diseases should be cautious as it might exacerbate their condition.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Sleep fragmentation
Secondary study objectives
Cognition
Mood

Awards & Highlights

Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Stepped careExperimental Treatment1 Intervention
One hour of daily bright light exposure in the afternoon
Group II: Standard of careActive Control1 Intervention
One hour of daily bright light exposure beginning one hour after wake time.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Light therapy
2004
N/A
~370

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,491 Previous Clinical Trials
17,518,044 Total Patients Enrolled
9 Trials studying Mood Disorders
509 Patients Enrolled for Mood Disorders
National Institute on Aging (NIA)NIH
1,805 Previous Clinical Trials
28,194,737 Total Patients Enrolled
2 Trials studying Mood Disorders
20 Patients Enrolled for Mood Disorders
~80 spots leftby May 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top